Welcome to LookChem.com Sign In|Join Free

CAS

  • or

87530-14-1

Post Buying Request

87530-14-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

87530-14-1 Usage

Description

3-[(3-Amino-propyl)-Methyl-amino]-propyl-carbamic acid tert-butyl ester is a chemical compound with the molecular formula C11H24N2O2, derived from carbamic acid and featuring a tert-butyl ester group. 3-[(3-AMino-propyl)-Methyl-aMino]-propyl-carbaMic acid tert-butyl ester is characterized by a central carbamic acid moiety connected to a 3-aminopropylmethylamino group and a 3-aminopropyl group, making it a versatile building block in organic synthesis and pharmaceutical research for creating bioactive compounds.

Uses

Used in Pharmaceutical Research:
3-[(3-Amino-propyl)-Methyl-amino]-propyl-carbamic acid tert-butyl ester is used as a building block in the pharmaceutical industry for the development of new therapeutic agents targeting various diseases. Its unique structure allows for the creation of diverse bioactive compounds with potential medicinal applications.
Used in Organic Synthesis:
In the field of organic synthesis, 3-[(3-Amino-propyl)-Methyl-amino]-propyl-carbamic acid tert-butyl ester serves as an important intermediate compound, facilitating the synthesis of a wide range of complex molecules with specific functionalities.
Used in Agriculture:
3-[(3-Amino-propyl)-Methyl-amino]-propyl-carbamic acid tert-butyl ester may also find applications in the agricultural industry, potentially contributing to the development of new agrochemicals or enhancing the properties of existing ones.
Used in Materials Science:
3-[(3-AMino-propyl)-Methyl-aMino]-propyl-carbaMic acid tert-butyl ester could be utilized in materials science for the development of novel materials with specific properties, such as improved mechanical strength, thermal stability, or chemical resistance, depending on the desired application.

Check Digit Verification of cas no

The CAS Registry Mumber 87530-14-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,7,5,3 and 0 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 87530-14:
(7*8)+(6*7)+(5*5)+(4*3)+(3*0)+(2*1)+(1*4)=141
141 % 10 = 1
So 87530-14-1 is a valid CAS Registry Number.

87530-14-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name Carbamic acid, N-[3-[(3-aminopropyl)methylamino]propyl]-, 1,1-dimethylethyl ester

1.2 Other means of identification

Product number -
Other names Carbamic acid, [3-[(3-aminopropyl)methylamino]propyl]-, 1,1-dimethylethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:87530-14-1 SDS

87530-14-1Relevant articles and documents

Synthesis of ferrocenylcarbodiimide as a convenient electrochemically active labeling reagent for nucleic acids

Mukumoto, Kosuke,Nojima, Takahiko,Takenaka, Shigeori

, p. 11705 - 11715 (2005)

Ferrocenylcarbodiimides carrying different redox potentials, 1 and 2, were designed and synthesized as convenient electrochemically active labeling reagents for nucleic acids, which may be used as dually labeling reagents of nucleic acids like Cy3 and Cy5 dyes. These reagents could react with the imino unit of thymine or guanine base on DNA or of uracil base on RNA under a basic buffer condition to yield a labeled product quantitatively in a short period of time. The current responses of the labeled DNAs in square wave voltammetric (SWV) measurement showed a good linear correlation with the amount of the hybridized ones. DNAs labeled with the two different reagents, 1 and 2, could be detected electrochemically at different potentials after hybridization with a DNA probe-immobilized gold electrode.

Cyclic Naphthalene Diimide Dimer with a Strengthened Ability to Stabilize Dimeric G-Quadruplex

Takeuchi, Ryusuke,Zou, Tingting,Wakahara, Daiki,Nakano, Yoshifumi,Sato, Shinobu,Takenaka, Shigeori

, p. 8691 - 8695 (2019)

A new type of dimeric cyclic naphthalene diimide derivatives (cNDI-dimers) carrying varied linker length were designed and synthesized to recognize dimeric G-quadruplex structures. All of the cNDI-dimers exhibited a high preference for recognizing G-quadruplex structures, and significantly enhanced the thermal stability of the dimeric G-quadruplex structure over the cNDI monomer by increasing the melting temperature by more than 23 °C, which indicated the strengthened ability of cNDI dimers for stabilizing dimeric G-quadruplex. cNDI dimers also showed a stronger ability to inhibit telomerase activity and stop telomere DNA elongation than cNDI monomer, which showed an improved anticancer potentiality for further therapeutic application.

METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE

-

Paragraph 00423; 00453; 00454; 00455, (2021/08/13)

The present disclosure relates to compounds and methods for modulating the expression of dmpk, and treating diseases and conditions in which dmpk plays an active role. The compound can be a transcription modulator molecule having a first terminus, a second terminus, and oligomeric backbone, wherein: a) the first terminus comprises a DNA-binding moiety capable of noncovalently binding to a nucleotide repeat sequence CAG or CTG; b) the second terminus comprises a protein-binding moiety binding to a regulatory molecule that modulates an expression of a gene comprising the nucleotide repeat sequence CAG or CTG; and c) the oligomeric backbone comprising a linker between the first terminus and the second terminus.

COMPOUNDS AND METHODS FOR MODULATING RNA FUNCTION

-

Paragraph 00435; 00436, (2018/02/28)

The present invention provides compounds, compositions thereof, and methods of using the same.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 87530-14-1